FONTES DE INFORMAÇÃO
Acervos Bibliográficos
BVS DIP
Inovação e propriedade intelectual
Memórias do IOC
Obras Raras
Teses Fiocruz
Videoteca
E mais...
SERVIÇOS
Catalogação na fonte
Comutação
Conservação e preservação
Ebooks
Empréstimo pessoal
Empréstimo entre bibliotecas
Formulário de inscrição
Mesa de Quarta-feira
Novas Aquisições
Reserva
Solicitação de cópias
Visitas orientadas
Ficha Catalográfica
PRODUTOS
Boletim
Exposição
Série Biografias
Série Doenças
Série Fontes de Referências
UTILIDADES
Conveniências no local
Normalização
Como chegar
Fale Conosco
Mapa do sítio
Nossa equipe
Perguntas freqüentes
INFLUENZA
(1)
CHIN-YEE, B. H. et al. Attitudes toward vaccination for pandemic H1N1 and seasonal influenza in patients with hematologic malignancies. Journal of supportive oncology, Huntington, v. 9, n. 4, p. 156-160, July/Aug. 2011.
(2)
KOK, J.; DWYER, D. E. How common was 2009 pandemic influenza A H1N1? Lancet infectious diseases, New York, v. 11, n. 6, p. 423-424, June 2011.
(3)
PIET, B. et al. CD8+ T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. Journal of clinical investigation, New York, v. 121, n. 6, p. 2254-2263, June 2011.
(4)
WILLIAMS, D. J. et al. Influenza coinfection and outcomes in children with complicated pneumonia. Archives of pediatrics and adolescent medicine, Chicago, v. 165, n. 6, p. 506-512, June 2011.
(5)
WILSON, K. C.; SCHÜNEMANN, H. J. An appraisal of the evidence underlying performance measures for community-acquired pneumonia. American journal of respiratory and critical care medicine, New York, v. 183, n. 11, p. 1454-1462, June 2011.
(6)
ROA, P. L. et al. Comparison of real-time RT-PCR, shell vial culture, and conventional cell culture for the detection of the pandemic influenza A (H1N1) in hospitalized patients. Diagnostic microbiology and infectious disease, New York, v. 69, n. 4, p. 428-431, Apr. 2011.
(7)
HEINONEN, S. et al. Feasibility of diagnosing influenza within 24gee hours of symptom onset in children 1-3gee years of age. European journal of clinical microbiology and infectious diseases, Berlin, v. 30, n. 3, p. 387-392, Mar. 2011.
(8)
ALONSO, M. et al. Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza. Journal of clinical virology, Amsterdam, v. 50, n. 2, p. 114-118, Feb. 2011.
(9)
ELLEBEDY, A. H. et al. Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59. Proceedings of the national academy of sciences of the United States of América, Washington, v. 108, n. 7, p. 2927-2932, Feb. 2011.
(10)
GO, Y. M. et al. Increased inflammatory signaling and lethality of influenza H1N1 by nuclear thioredoxin-1. PLoS One, San Francisco, v. 6, n. 4, p. e18918, 2011.